We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.
Lexology logo






  Request new password

Search results

Order by most recent / most popular / relevance

Results: 1-10 of 87

French Competition Authority fines Sanofi-Aventis EUR 40.6 million for disparaging competing generic products

  • Baker Botts LLP
  • -
  • France
  • -
  • May 31 2013

On 14 May 2013, the French Autorité de la concurrence ("Autorité") fined Sanofi-Aventis ("Sanofi") EUR 40.6 million (approximately USD

French Sunshine Act implementedawaiting guidance

  • Drinker Biddle & Reath LLP
  • -
  • France
  • -
  • June 13 2013

As pharmaceutical and device manufacturers and others are scrambling to finalize interpretations and implementation of the U.S. Physician Payment

A brave new world? The "French Sunshine Act" imposes online disclosure of contracts with HCPs, as well as of payments of "advantages" to HCPs, dating back to 01 January 2012

  • Reed Smith LLP
  • -
  • France
  • -
  • May 23 2013

In probably one the longest-awaited decrees in recent French regulation, the French Ministry of Health published on 22 May 2013, the application

Reimbursement of biosimilars

  • Taylor Wessing LLP
  • -
  • Austria, France, United Kingdom
  • -
  • May 28 2013

Improvements in technology and pressures to diversify business models away from small molecule drugs are just two of the factors that are focussing

French Sunshine Act finally implemented

  • McDermott Will & Emery
  • -
  • France
  • -
  • May 22 2013

The decree implementing French Law No. 2011-2012 on the Strengthening of Health Protection for Medicinal and Health Products (the decree), known as

Dispelling the Myriad gene patent harmonization myth

  • Foley & Lardner LLP
  • -
  • Australia, Canada, European Union, France, Germany, Japan, USA
  • -
  • April 30 2013

In the wake of the Supreme Court oral arguments in the Myriad "gene patent" case, most commentators are predicting that the Court will uphold the

Remaining French Sunshine regulations have finally been adopted

  • Hogan Lovells
  • -
  • France
  • -
  • May 23 2013

French Decree n2013-414 dated 21 May 2013 implementing the French Sunshine regulations was published in the Official Journal of 22 May 2013 (the

France - Implementation of ‘Sunshine' provisions for pharmaceutical, medical device, and cosmetic companies

  • Hunton & Williams LLP
  • -
  • France
  • -
  • May 24 2013

After the Netherlands, Slovakia, and the UK, it is now France's turn to impose Sunshine-like obligations on the pharmaceutical industry. Soon

French Ministry of Health provides guidance on recent 'Sunshine' provisions

  • Hunton & Williams LLP
  • -
  • France
  • -
  • June 13 2013

As discussed in our previous Alert, the French government has imposed Sunshine-like obligations on the pharmaceutical industry. Article 2 of Law No

New legal framework for transparency in interactions between industry and HCPs

  • Baker & McKenzie
  • -
  • France
  • -
  • February 1 2012

The Law of 19 December 2011 provides for (a) a new set of transparency rules regarding the interests that experts involved in the various decision-making processes around life sciences products may have with companies in the life sciences sector

Current Search

Suggested Facets

Author

Firm Name

Jurisdiction

Workarea

© Copyright 2006-2013 Globe Business Publishing Ltd | Cookies | Disclaimer | Privacy policy